Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

US researchers report on a randomised study in which 35 patients alternated between the two most different generic lamotrigine products and found no significant changes in seizure frequency or adverse events between the two

Different generics of lamotrigine (pictured) used to treat epilepsy had no discernable difference in efficacy